DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Gibson CM, Chi G, Halaby R. , et al; APEX Investigators.
Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill venous thromboembolism prevention with extended duration betrixaban).

Circulation 2017;
135 (07) 648-655

Gibson CM, Chi G, Halaby R. , et al; APEX Investigators.
Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill venous thromboembolism prevention with extended duration betrixaban).

Circulation 2017;
135 (07) 648-655

Download Bibliographical Data

Search in:
Access: